Comparative Proteomic Analysis of Tumor Mesenchymal-Like Stem Cells Derived from High Grade Versus Low Grade Gliomas

Overview

Journal Cell J

Specialty Cell Biology

Date 2017 Jul 4

PMID 28670517

Citations 6

Authors

Mousa Taghipour

Aydine Omidvar

Mahboobeh Razmkhah

Abbas Ghaderi

Zahra Mojtahedi

Affiliations

Soon will be listed here.

Abstract

Objective: Gliomas are the most common primary brain tumors, and have been ranked as the fourth leading cause of cancer death. Tumor mesenchymal-like stem cells (tMSCs) contribute to the aggressive behavior of glial tumors by providing a favorable microenvironment for the malignant cells. The aim of our study was to identify differential proteome of tMSCs derived from low vs. high grade glioma tumors.

Materials And Methods: Patients with newly diagnosed low and high grade gliomas were included in this case control study. tMSCs were isolated from tumors using enzymatic digestion validated by flow cytometer analysis after sub-culturing. Differential proteomic analysis of tMSCs derived from low and high grade tumors was performed by two-dimensional gel electrophoresis and mass spectrometry. Protein spots with more than two fold differences and P values below 0.05 were considered as differentially expressed ones.

Results: In tMSCs isolated from low and high grade gliomas, different isoforms of mesenchymal-related proteins vimentin and transgelin were differentially expressed. Overexpressed proteins in tMSCs isolated from low grade gliomas were mitochondrial manganese-containing superoxide dismutase (Mn-SOD), 40S ribosomal protein SA, and GTP-binding nuclear protein, while in tMSCs isolated from high grade gliomas, cathepsin B, endoplasmin, ezrin, peroxiredoxin1, and pyruvate kinase (PK) were found to be significantly overexpressed.

Conclusion: For the first time, we analyzed the differential proteomic profiles of tMSCs isolated from glioma tumors with different grades. It was found that molecules related to mesenchymal cells (vimentin and transglin), in addition to those related to tumor aggressiveness with potential secretory behavior (e.g. cathepsin B) were among differentially expressed proteins.

Citing Articles

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.

Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y J Hematol Oncol. 2024; 17(1):31.

PMID: 38720342 PMC: 11077829. DOI: 10.1186/s13045-024-01544-7.

Proteomics Study of Mesenchymal Stem Cell-Like Cells Obtained from Tumor Microenvironment of Patients with Malignant and Benign Salivary Gland Tumors.

Haghshenas M, Erfani N, Khansalar S, Khademi B, Ashraf M, Razmkhah M Cell J. 2022; 24(4):196-203.

PMID: 35674025 PMC: 9124444. DOI: 10.22074/cellj.2022.7844.

Study on the differential proteomics of rat hippocampal mitochondria during deep hypothermic circulatory arrest.

Gao Y, Han X, Wei L, Yuan Y, Zhao C, Zhang M Ann Transl Med. 2021; 9(4):346.

PMID: 33708973 PMC: 7944285. DOI: 10.21037/atm-21-95.

Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?.

Clavreul A, Menei P Cancers (Basel). 2020; 12(9).

PMID: 32942567 PMC: 7565954. DOI: 10.3390/cancers12092628.

Perspectives for Ezrin and Radixin in Astrocytes: Kinases, Functions and Pathology.

Derouiche A, Geiger K Int J Mol Sci. 2019; 20(15).

PMID: 31382374 PMC: 6695708. DOI: 10.3390/ijms20153776.

References

Saidi A, Hagedorn M, Allain N, Verpelli C, Sala C, Bello L . Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer. 2009; 125(5):1054-64. DOI: 10.1002/ijc.24380. View

Poschmann G, Grzendowski M, Stefanski A, Bruns E, Meyer H, Stuhler K . Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress. Biochim Biophys Acta. 2014; 1854(6):624-31. DOI: 10.1016/j.bbapap.2014.11.011. View

Hu T, Xie N, Qin C, Wang J, You Y . Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/β-catenin signaling pathway. Tumour Biol. 2015; 36(12):9357-64. DOI: 10.1007/s13277-015-3635-4. View

Bruneau N, Lombardo D, Bendayan M . Participation of GRP94-related protein in secretion of pancreatic bile salt-dependent lipase and in its internalization by the intestinal epithelium. J Cell Sci. 1998; 111 ( Pt 17):2665-79. DOI: 10.1242/jcs.111.17.2665. View

Bronte V . Tumor cells hijack macrophages via lactic acid. Immunol Cell Biol. 2014; 92(8):647-9. DOI: 10.1038/icb.2014.67. View

Riddell J, Wang X, Minderman H, Gollnick S . Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. J Immunol. 2009; 184(2):1022-30. PMC: 2955897. DOI: 10.4049/jimmunol.0901945. View

Aldape K, Simmons M, Davis R, Miike R, Wiencke J, Barger G . Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer. 2000; 88(10):2342-9. View

Kong B, Shin H, Kim S, Mok H, Shim J, Lee J . Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma. Int J Oncol. 2013; 42(5):1754-62. DOI: 10.3892/ijo.2013.1856. View

Woo I, Jang H, Eun S, Kim H, Ham S, Kim H . Ran suppresses paclitaxel-induced apoptosis in human glioblastoma cells. Apoptosis. 2008; 13(10):1223-31. DOI: 10.1007/s10495-008-0247-0. View

10.

Wu G, Sun X, Yuan H, Hu M . Ezrin gene expression and protein production in the CD44(+) subpopulation of SCC-9 cells in a malignant oral cancer cell line in vitro. J Oral Maxillofac Surg. 2013; 71(3):e151-7. DOI: 10.1016/j.joms.2012.11.011. View

11.

Noerholm M, Balaj L, Limperg T, Salehi A, Zhu L, Hochberg F . RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012; 12:22. PMC: 3329625. DOI: 10.1186/1471-2407-12-22. View

12.

Zhong W, Oberley L, Oberley T, St Clair D . Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene. 1997; 14(4):481-90. DOI: 10.1038/sj.onc.1200852. View

13.

Roshy S, Sloane B, Moin K . Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 2003; 22(2-3):271-86. DOI: 10.1023/a:1023007717757. View

14.

Mukherjee J, Phillips J, Zheng S, Wiencke J, Ronen S, Pieper R . Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. PLoS One. 2013; 8(2):e57610. PMC: 3581484. DOI: 10.1371/journal.pone.0057610. View

15.

Li Q, Li N, Liu C, Xu R, Kolosov V, Perelman J . Ezrin/Exocyst complex regulates mucin 5AC secretion induced by neutrophil elastase in human airway epithelial cells. Cell Physiol Biochem. 2015; 35(1):326-38. DOI: 10.1159/000369699. View

16.

Rempel S, Rosenblum M, Mikkelsen T, Yan P, Ellis K, Golembieski W . Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 1994; 54(23):6027-31. View

17.

Hong S, Misek D, Wang H, Puravs E, Hinderer R, Giordano T . Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer. Biomark Insights. 2008; 1:175-183. PMC: 2528299. View

18.

Landriscina M, Remiddi F, Ria F, Palazzotti B, De Leo M, Iacoangeli M . The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br J Cancer. 1996; 74(12):1877-85. PMC: 2074812. DOI: 10.1038/bjc.1996.648. View

19.

Demchik L, Sameni M, Nelson K, Mikkelsen T, Sloane B . Cathepsin B and glioma invasion. Int J Dev Neurosci. 1999; 17(5-6):483-94. DOI: 10.1016/s0736-5748(99)00011-8. View

20.

Wang E, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C . Alternative isoform regulation in human tissue transcriptomes. Nature. 2008; 456(7221):470-6. PMC: 2593745. DOI: 10.1038/nature07509. View